Articles

Chewy’s stock is having its best day ever after yet another earnings beat

Chewy’s stock soared toward their best day in a year, after the online pet products seller reported another quarterly earnings beat, amid strength in margins and sales per active customer.

Marathon bondholders signaled deal ahead of ConocoPhillips merger announcement

Marathon Oil bonds were rallying Wednesday on the heels of the announcement of the company’s $17.5 billion acquisition by ConocoPhillips, but investors had already been moving money into the energy company ahead of the deal.

Medicare drug plans are slashing drug coverage — and it’s going to impact everyone

The private health insurance companies that administer Medicare drug plans have drastically increased the number of exclusions and restrictions

Goldman Sachs executive Beth Hammack named next president of Cleveland Fed

Will be a voting FOMC member this year

2024 is being called ‘the year of the dividend.’ These 5 stocks keep on giving.

Declining U.S. interest rates will boost yield-paying shares.

Here’s one more reason why day trading and market timing can cost you

A surprisingly small number of days account for the market’s entire annual return.

AI replicating human thinking is more Big Tech ‘fake-it-till-you-make-it’ hype 

ChatGPT and its peers do not understand what words mean.

Indian option traders bet on Modi election victory as derivative market booms

Option bets on India’s stock market suggest it will move by less than 5% in either direction in the day after the country’s election concludes

American Airlines’ profit-view cut draws at least one downgrade as stock swoons

Seaport cuts rating on AAL to neutral from buy while JP Morgan’s Jamie Baker says he’s more disappointed than surprised

Commodities have been on a tear — and the next trade is in the stock market, say these strategists.

The next way to play the commodities boom is in the stock market, say these strategists, who say the long copper/short oil trade has played out.

I’m a millennial mom. Why are world leaders looking at me to fix the birth-rate problem?

The panic about falling birthrates is divorced from the realities of raising kids in today’s world

Merck could pay up to $3 billion to boost its retinal disease candidate pipeline

Merck announced Wednesday an agreement to buy privately held Eyebiotech Ltd., an ophthalmology-focused biotechnology company, in a deal that could be valued at up to $3 billion.
1 1,355 1,356 1,357 1,358 1,359 2,553